• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于抗原节俭的流感疫苗设计方法。

An Antigenic Thrift-Based Approach to Influenza Vaccine Design.

作者信息

Bolton Jai S, Klim Hannah, Wellens Judith, Edmans Matthew, Obolski Uri, Thompson Craig P

机构信息

Peter Medawar Building for Pathogen Research, Oxford OX1 3SY, UK.

Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.

出版信息

Vaccines (Basel). 2021 Jun 16;9(6):657. doi: 10.3390/vaccines9060657.

DOI:10.3390/vaccines9060657
PMID:34208489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8235769/
Abstract

The antigenic drift theory states that influenza evolves via the gradual accumulation of mutations, decreasing a host's immune protection against previous strains. Influenza vaccines are designed accordingly, under the premise of antigenic drift. However, a paradox exists at the centre of influenza research. If influenza evolved primarily through mutation in multiple epitopes, multiple influenza strains should co-circulate. Such a multitude of strains would render influenza vaccines quickly inefficacious. Instead, a single or limited number of strains dominate circulation each influenza season. Unless additional constraints are placed on the evolution of influenza, antigenic drift does not adequately explain these observations. Here, we explore the constraints placed on antigenic drift and a competing theory of influenza evolution - antigenic thrift. In contrast to antigenic drift, antigenic thrift states that immune selection targets epitopes of limited variability, which constrain the variability of the virus. We explain the implications of antigenic drift and antigenic thrift and explore their current and potential uses in the context of influenza vaccine design.

摘要

抗原漂移理论认为,流感病毒是通过突变的逐渐积累而进化的,这会降低宿主对先前毒株的免疫保护。流感疫苗就是在抗原漂移的前提下设计的。然而,流感研究的核心存在一个悖论。如果流感主要通过多个表位的突变进化,那么多种流感毒株应该会同时传播。如此众多的毒株会使流感疫苗很快失效。相反,每个流感季节主导传播的是单一或数量有限的毒株。除非对流感的进化施加额外的限制,否则抗原漂移无法充分解释这些现象。在这里,我们探讨对抗原漂移的限制以及一种与之竞争的流感进化理论——抗原节约。与抗原漂移相反,抗原节约理论认为免疫选择针对的是变异性有限的表位,这限制了病毒的变异性。我们解释了抗原漂移和抗原节约的含义,并探讨了它们在流感疫苗设计背景下的当前及潜在用途。

相似文献

1
An Antigenic Thrift-Based Approach to Influenza Vaccine Design.一种基于抗原节俭的流感疫苗设计方法。
Vaccines (Basel). 2021 Jun 16;9(6):657. doi: 10.3390/vaccines9060657.
2
Influenza vaccination and the 'diversity paradox'.流感疫苗接种与“多样性悖论”。
Hum Vaccin Immunother. 2018;14(12):3005-3009. doi: 10.1080/21645515.2018.1504596. Epub 2018 Sep 21.
3
The antigenic evolution of influenza: drift or thrift?流感的抗原进化:漂变还是节省?
Philos Trans R Soc Lond B Biol Sci. 2013 Feb 4;368(1614):20120200. doi: 10.1098/rstb.2012.0200. Print 2013 Mar 19.
4
A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.一种病毒样颗粒疫苗接种策略通过增强针对血凝素茎部的中和抗体来扩大其对H3N2抗原漂移的耐受性。
Antiviral Res. 2017 Apr;140:62-75. doi: 10.1016/j.antiviral.2017.01.010. Epub 2017 Jan 14.
5
Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses.评估季节性甲型(H3N2)和甲型(H1N1)pdm09流感病毒的抗原漂移
PLoS One. 2015 Oct 6;10(10):e0139958. doi: 10.1371/journal.pone.0139958. eCollection 2015.
6
Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.泰国2015年流行季甲型H3N2流感病毒血凝素的基因和抗原特性
Virus Genes. 2016 Oct;52(5):711-5. doi: 10.1007/s11262-016-1347-5. Epub 2016 May 4.
7
Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.灭活 H5 疫苗种株对不同鸭/广东谱系 H5N1 高致病性禽流感病毒的交叉保护作用。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.00720-20.
8
Use of antigenic cartography in vaccine seed strain selection.抗原图谱在疫苗种子株选择中的应用。
Avian Dis. 2010 Mar;54(1 Suppl):220-3. doi: 10.1637/8740-032509-ResNote.1.
9
Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.对流感病毒进行定向选择会产生与正在传播的人类病毒分离株相匹配的抗原变异体,并逃避疫苗介导的免疫保护。
Immunology. 2016 Jun;148(2):160-73. doi: 10.1111/imm.12594. Epub 2016 Mar 30.
10
Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.抗体滴度对于疫苗预防来自印度尼西亚的H5N1高致病性禽流感病毒自然抗原漂移变体攻击具有阳性预测价值。
J Virol. 2015 Apr;89(7):3746-62. doi: 10.1128/JVI.00025-15. Epub 2015 Jan 21.

引用本文的文献

1
Multivalent Exosome Based Protein Vaccine: A "Mix and Match" Approach to Epidemic Viruses' Challenges.基于多价外泌体的蛋白质疫苗:应对流行性病毒挑战的“混合搭配”方法。
Vaccines (Basel). 2025 Feb 28;13(3):258. doi: 10.3390/vaccines13030258.
2
Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza.广谱流感mRNA疫苗的优势及其对肺部流感的影响。
Vaccines (Basel). 2024 Dec 7;12(12):1382. doi: 10.3390/vaccines12121382.
3
Multiple Vaccines and Strategies for Pandemic Preparedness of Avian Influenza Virus.

本文引用的文献

1
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.嵌合血凝素基通用流感病毒疫苗方法在一项随机、安慰剂对照的 I 期临床试验中诱导了广泛和持久的免疫。
Nat Med. 2021 Jan;27(1):106-114. doi: 10.1038/s41591-020-1118-7. Epub 2020 Dec 7.
2
Asynchrony between virus diversity and antibody selection limits influenza virus evolution.病毒多样性与抗体选择之间的失同步限制了流感病毒的进化。
Elife. 2020 Nov 11;9:e62105. doi: 10.7554/eLife.62105.
3
A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade.
多种疫苗和策略应对禽流感病毒的大流行准备。
Viruses. 2023 Aug 4;15(8):1694. doi: 10.3390/v15081694.
4
Promising strategy for developing mRNA-based universal influenza virus vaccine for human population, poultry, and pigs- focus on the bigger picture.为人类、家禽和猪开发基于 mRNA 的通用流感病毒疫苗的有前景策略——着眼大局。
Front Immunol. 2022 Oct 17;13:1025884. doi: 10.3389/fimmu.2022.1025884. eCollection 2022.
十年回顾:2010 年代临床试验中通用流感疫苗的系统评价。
Viruses. 2020 Oct 20;12(10):1186. doi: 10.3390/v12101186.
4
Defining and Manipulating B Cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses against Influenza Virus.定义和操纵B细胞免疫显性层次结构以引发针对流感病毒的广泛中和抗体反应。
Cell Syst. 2020 Dec 16;11(6):573-588.e9. doi: 10.1016/j.cels.2020.09.005. Epub 2020 Oct 7.
5
Role of Post-translational Modifications in Influenza A Virus Life Cycle and Host Innate Immune Response.翻译后修饰在甲型流感病毒生命周期和宿主天然免疫反应中的作用
Front Microbiol. 2020 Sep 4;11:517461. doi: 10.3389/fmicb.2020.517461. eCollection 2020.
6
Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.比较 2018-2019 季节来源于鸡蛋、细胞和重组血凝素的四价流感疫苗诱导的 A(H3N2)中和抗体反应。
Clin Infect Dis. 2021 Dec 6;73(11):e4312-e4320. doi: 10.1093/cid/ciaa1352.
7
A large effective population size for established within-host influenza virus infection.建立在宿主内流感病毒感染的大有效种群规模。
Elife. 2020 Aug 10;9:e56915. doi: 10.7554/eLife.56915.
8
Using ggtree to Visualize Data on Tree-Like Structures.使用 ggtree 可视化树状结构数据。
Curr Protoc Bioinformatics. 2020 Mar;69(1):e96. doi: 10.1002/cpbi.96.
9
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.嵌合血凝素为基础的通用流感病毒疫苗候选物的免疫原性:一项随机、安慰剂对照、1 期临床试验的中期结果。
Lancet Infect Dis. 2020 Jan;20(1):80-91. doi: 10.1016/S1473-3099(19)30393-7. Epub 2019 Oct 17.
10
M2e-based universal influenza vaccines: a historical overview and new approaches to development.基于 M2e 的通用流感疫苗:历史概述及新的开发方法。
J Biomed Sci. 2019 Oct 19;26(1):76. doi: 10.1186/s12929-019-0572-3.